Latest Anti-diabetic medication Stories
Findings Also Show Some Patients Discontinue Use of Other Blood-Glucose-Lowering Medications after Initiation of INVOKANA® RARITAN, N.J., May 18, 2015 /PRNewswire/ -- Janssen Pharmaceuticals,
Parker Waichman, which has been actively involved in the Actos Litigation and represents many clients, notes that the deadline to enter into an Actos claim with the firm is rapidly approaching.
PLAINSBORO, N.J., April 22, 2015 /PRNewswire/ -- Novo Nordisk today announced that Saxenda(® )(liraglutide [rDNA origin] injection) is now available in the United States.
DEERFIELD, Ill. and OSAKA, Japan, April 14, 2015 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. Inc.
New market research report “Global Diabetes Drug Market & Pipeline Insight 2015” drawn up by Kuick Research is now available at MarketPublishers.com. London,
Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at
Merkerson Visits Memphis, Tennessee on March 20 With America's Diabetes Challenge: Get to Your Goals Program KENILWORTH, N.J., March 20, 2015 /PRNewswire/ -- Merck (NYSE: MRK), known
OSAKA, Japan, March 9, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular
The $1.3 million in punitive damages is in addition to a $2.3 million award to the plaintiff, who alleges that Actos caused him to develop bladder cancer.
NORWALK, Conn., Feb.
- A young chicken: also used as a pet name for children.